News by Subject Medicine & Health

Fecal microbiota transplant (FMT), or the transfer of stool from a healthy donor to a patient, has been found effective in reversing severe, recurring diarrheal infections from Clostridiodes difficile in adults by restoring a normal microbiome. Now, the largest study to date of FMT in children finds the procedure to be safe and effective in eradicating an infection that is on the rise among children, even those without known risk factors.

Up to 1 in 7 kidney donors and recipients may have a type of genetic incompatibility that leads to organ rejection, researchers at Columbia University have found.

After receiving a kidney transplant, children may experience worrisome quality-of-life changes that underscore the importance of screening transplant recipients for psychosocial function, according to Children's research presented during the 10th Congress of the International Pediatric Transplant Association.

Harvard University researchers used single-cell sequencing to identify a protein expressed uniquely by insulin-producing beta cells created from stem cells in the laboratory. By targeting the protein and adding a physical enrichment method developed by collaborators at Semma Therapeutics, the purity of beta cells improved from 30 to 80%. Improved control over the beta cell production process will allow researchers to refine cell therapy for patients with type 1 diabetes.

A new technique to rehabilitate lungs that are too damaged to be considered for transplant could benefit an increasing population of patients with end-stage lung disease.

A new study shows that a potential treatment for ischemia- reperfusion injury is safe for humans.